Skip to content

ELISA-VIDITEST anti-CMV IgG (CSF)

by VIDIA spol. s r.o. EUDAMED

Active European Union

Ref ODZ-102/5STModel ELISA-VIDITEST anti-CMV IgG (CSF)

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-58594036041023 Basic UDI-DIDate30 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Model / Reference
ELISA-VIDITEST anti-CMV IgG (CSF), ODZ-102/5ST
Primary DI / UDI-DI
58594036041023
Basic UDI-DI
B-58594036041023
EMDN Code
W0105040203 Cmv igg
Device Class
Class IVD Annex II List B
Market of Registration
Czechia

Manufacturer details

EUDAMED SRN
CZ-MF-000036964

Other devices from VIDIA spol. s r.o.

See all devices from VIDIA spol. s r.o. →

Properties

  • Human Tissues
  • Microbial Substances
  • Professional Testing

Other properties (7)

  • Sterile: No
  • Animal Tissues: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No